s 20928 has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, AR; Dai, J; Dubocovich, ML; Hill, SM; Yuan, L | 1 |
1 other study(ies) available for s 20928 and Adenocarcinoma
Article | Year |
---|---|
MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Intercellular Signaling Peptides and Proteins; Melatonin; Mucins; Muscle Proteins; Naphthalenes; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuropeptides; Peptides; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Melatonin; Recombinant Fusion Proteins; RNA, Messenger; RNA, Neoplasm; Transfection; Trefoil Factor-2; Trefoil Factor-3; Tumor Cells, Cultured | 2002 |